ClinConnect ClinConnect Logo
Search / Trial NCT06898307

Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART

Launched by UNIVERSITY HOSPITAL OF FERRARA · Mar 26, 2025

Trial Information

Current as of April 29, 2025

Recruiting

Keywords

Cardiogenetic

ClinConnect Summary

The ARRHYTHMIC GENE-HEART trial is studying how gene tests can help diagnose and treat patients with genetic heart diseases that cause abnormal heart rhythms, known as arrhythmias. This research is happening at the Cardiogenetic Center in Ferrara, Italy, where they aim to gather detailed information about patients who are suspected of having these conditions. By collecting data on patients' health, family history, and treatment outcomes, the study hopes to improve our understanding of these genetic issues and how they affect patients over time.

To be eligible for this study, participants should be patients who have been evaluated at the Cardiogenetic Center and have a confirmed genetic heart disease. If someone decides to join, they can expect to provide information about their health and family history, and they will be monitored over time to see how their condition progresses and how well different treatments work. It’s important to note that patients who do not have a genetic heart condition or who refuse to give consent will not be able to participate in this trial.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients evaluated at the Cardiogenetic Center of the University of Ferrara in Ferrara, Italy.
  • Having a proven cardiogenetic disease
  • Exclusion Criteria:
  • Refuse to provide informed consents
  • Patients not having a cardiogenic disease

About University Hospital Of Ferrara

The University Hospital of Ferrara, a leading academic medical institution in Italy, is dedicated to advancing healthcare through innovative research and clinical excellence. Affiliated with the University of Ferrara, the hospital is known for its commitment to integrating cutting-edge scientific inquiry with patient care. With a multidisciplinary approach, the institution conducts a wide range of clinical trials aimed at enhancing treatment methodologies and improving patient outcomes in various medical fields. The University Hospital of Ferrara prioritizes ethical standards and patient safety, fostering a collaborative environment that engages researchers, healthcare professionals, and patients in the pursuit of medical advancement.

Locations

Ferrara, , Italy

Patients applied

0 patients applied

Trial Officials

Cristina Balla, MD PhD

Principal Investigator

Università degli Studi di Ferrara

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported